top of page
Companion Diagnostics Development
Leveraging our diagnostic development expertise to create companion diagnostics that are critical for identifying the right patients for the right treatments, enabling a more precise, targeted approach to treatment, improving patient outcomes, and advancing the field of medicine, from clinical trials through to commercialisation.
Biomarker Discovery and Validation
Identifying and validating biomarkers that predict the efficacy and safety of pharmaceuticals, ensuring that treatments can be personalised to individual genetic profiles.
Assay Development and Optimisation
Creating assays that can detect these biomarkers with high sensitivity and specificity. This includes leveraging our expertise in NGS to develop reliable, reproducible diagnostic solutions.
bottom of page